GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » PB Ratio

Modalis Therapeutics (TSE:4883) PB Ratio : 3.15 (As of Mar. 24, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-24), Modalis Therapeutics's share price is 円89.00. Modalis Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 was 円28.21. Hence, Modalis Therapeutics's PB Ratio of today is 3.15.

The historical rank and industry rank for Modalis Therapeutics's PB Ratio or its related term are showing as below:

TSE:4883' s PB Ratio Range Over the Past 10 Years
Min: 0.63   Med: 2.5   Max: 21.38
Current: 3.23

During the past 6 years, Modalis Therapeutics's highest PB Ratio was 21.38. The lowest was 0.63. And the median was 2.50.

TSE:4883's PB Ratio is ranked worse than
71.2% of 941 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs TSE:4883: 3.23

During the past 12 months, Modalis Therapeutics's average Book Value Per Share Growth Rate was -64.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -42.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.80% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Modalis Therapeutics was 63.10% per year. The lowest was -42.50% per year. And the median was -13.20% per year.

Back to Basics: PB Ratio


Modalis Therapeutics PB Ratio Historical Data

The historical data trend for Modalis Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics PB Ratio Chart

Modalis Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 10.16 3.20 3.34 3.00

Modalis Therapeutics Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 2.39 3.00 3.14 2.48

Competitive Comparison of Modalis Therapeutics's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Modalis Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modalis Therapeutics's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modalis Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Modalis Therapeutics's PB Ratio falls into.



Modalis Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Modalis Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=89.00/28.214
=3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Modalis Therapeutics  (TSE:4883) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Modalis Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Modalis Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Modalis Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics Headlines

No Headlines